ArticleCureus2025
Hemostatic Effect of Oxidized Regenerated Cellulose in Simultaneous Bilateral Total Knee Arthroplasty: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Oxidized regenerated cellulose (ORC) is a biodegradable hemostatic agent widely used in surgical practice. However, its efficacy and safety in total knee arthroplasty (TKA), particularly in simultaneous bilateral procedures, remain underreported. Methods This retrospective study included patients who underwent simultaneous bilateral TKA at our institution. A total of 49 patients were analyzed and divided into two groups: the ORC group (n=21), in which ORC was used intraoperatively, and the non-ORC group (n=28). Perioperative hemoglobin (Hb) and hematocrit (Ht) levels were compared between groups, along with estimated blood loss (EBL) on postoperative days 4 and 7, calculated using the Gross formula. Transfusion rates and postoperative complications were also evaluated. Statistical analyses were performed using the Wilcoxon rank-sum test and chi-squared test. Results No significant preoperative differences in Hb or Ht values were observed between groups. However, both postoperative Hb/Ht levels and EBL on postoperative days 4 and 7 were significantly lower in the ORC group (p<0.05). No significant difference in transfusion rate was found between groups. Importantly, no postoperative complications directly related to ORC use were identified. Conclusion ORC demonstrated effective and safe hemostasis in simultaneous bilateral TKA, contributing to reduced postoperative blood loss without increasing complications. ORC may be a valuable adjunct for blood loss management in TKA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.